FGFR2-activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer cell models
Samantha J. Stehbens(The University of Queensland), Pamela M. Pollock(Queensland University of Technology)
Cited by 25
Related Papers
Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
|Molecular Cancer Research|2009|118
PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers
|Molecular Cancer Therapeutics|2017|51
Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status
|Molecular Cancer|2012|45
Persister state-directed transitioning and vulnerability in melanoma
|Nature Communications|2022|35